# Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.

> **NCT02359513** · PHASE4 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 51 (actual)

## Conditions studied

- Bulimia Nervosa

## Interventions

- **DRUG:** Antidepressants
- **DRUG:** Positron Emission Tomography (PET)

## Key facts

- **NCT ID:** NCT02359513
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-09
- **Primary completion:** 2021-11-12
- **Final completion:** 2022-03-11
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2022-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02359513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02359513, "Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02359513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*